News

Researchers may have found a test to diagnose neurological disorders such as Parkinson’s disease earlier, according to a new study published in the journal Physical Review Applied. The study, “Fluctuations in Protein Aggregation: Design of Preclinical Screening for Early Diagnosis of Neurodegenerative Disease,” was conducted by Giulio Costantini, from…

Recent research has shed light on the pathology of Parkinson’s disease by explaining how alpha-synuclein, a protein closely related to the disease, functions in a normal human brain. Findings may contribute to the design of future novel and appropriate therapies for Parkinson’s disease. The study, “Structural Basis Of Synaptic Vesicle Assembly…

NeuroDerm has started enrolling Parkinson’s disease (PD) patients in iNDiGO, a Phase 3 clinical trial evaluating the effectiveness of ND0612L, the company’s levodopa/carbidopa (LD/CD) subcutaneous liquid formulation. Levodopa and dopamine agonists, the first line of defense against Parkinson’s disease, are drugs commonly used to improve and control the symptoms of tremor, muscular…

A recent study suggests that a genetic mutation that disrupts a protein involved in the degradation of biological material within neurons allows waste products to accumulate, contributing to the pathology of Parkinson’s disease. Mutations in this protein, Vps35, have been associated with Parkinson’s disease, but until now, it was not…

A European Union research initiative called IMPACT is making headway into improving and individualizing deep brain stimulation (DBS) for Parkinson’s disease. DBS can be a treatment for Parkinson’s disease that has not responded to medication. DBS involves implanting an electrode in the brain and a stimulating device in the chest. The…

The World Parkinson Coalition (WPC) is teaming up again with the nonprofit Brian Grant Foundation (BGF), led by retired 12-year NBA power forward Brian Grant. He was diagnosed with young onset Parkinson’s disease at age 36. The foundation is committed to empowering people impacted by…

Victoza (liraglutide), a drug therapy for type 2 diabetes, is currently being evaluated in an ongoing clinical study to slow or stop the progression of Parkinson’s disease. This study is developed by the Linked Clinical Trials (LCT) initiative from The Cure Parkinson’s Trust in the United Kingdom, together with the Van Andel…

Researchers may have come a step closer to understanding the cause of Parkinson’s disease, in a study showing how the inability to degrade old mitochondria — the power plants that charge our cells — leads to the death of dopamine neurons. The findings also explain the role of the LRRK2 gene in…

Researchers from the University of Malta suggest that chemicals found in red wine may protect the brain and could potentially ward off Parkinson’s disease (PD). The report, “Putative role of red wine polyphenols against brain pathology in Alzheimer’s and Parkinson’s disease,” appeared in the journal Frontiers in Nutrition.

The nonprofit Parkinson’s Resources of Oregon (PRO) will unveil a series of Parkinson’s Ready training for the Portland Police Department, local hospitals and clinics (Legacy Health Systems), Portland International Airport security services (Transportation Security Administration), and local hotels in downtown Portland. The initiative is included in the organization’s program…